Blepharitis is an annoying, chronic inflammation of the eyelid margins that can cause red eyes, swollen eyelids, eye pain, itching, irritation, and blurry vision. It can also cause crusty, ...

Acute blepharitis typically lasts for a few weeks and resolves on its own. The market for blepharitis treatment in the United States is currently worth $300 million and is expected to grow to $340 ...

“Blepharitis can develop at any age, but it is more common in people over 40, began Giles Edmonds from Specsavers. He added: “Symptoms of the condition include itchy and sore eyelids, eyelids ...

Conditions associated Blepharitis include a red tender bump on the eyelid which is caused by an acute infection of the oil glands of the eyelid. The other is chalazion, condition which can follow ...

Recurrent or untreated blepharitis can also affect the eyelash follicles, causing your lashes to fall out, become sparse and start growing in weird directions, says Francesca Marchetti, ocular expert ...

Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that 102 patients in the NCX 4251 Mississippi Phase 2b blepharitis clinical trial have now been ...

Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that the upcoming Mississippi Phase 2 trial of its second clinical candidate, NCX 4251 0.1% ...

Mississippi Phase 2 trial will evaluate once-daily dosed NCX 4251 0.1% against placebo in blepharitis patients Trial is targeted to start in December 2020 with top-line results expected in Q4 2021 If ...